Nationwide implementation of PCSK9--targeted therapies after myocardial infarction and ischemic stroke: structural barriers and disparities in a universal healthcare system

Leqvio (inclisiran) - Novartis

P Sedova1; P Kala1; P Ostadal2; J Jarkovsky3; S Littnerova3; R Mikulik4; A Tomek5; A Tichopad6; V.K Somers7; R.D Brown8; M Vrablik9

May 11, 2026